Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Oxurion confirms continuation of discussions regarding its proposed acquisition…
Leuven, BELGIUM – 27 februari 2026 – 06:00 PM CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announces the extension of the negotiations relating to the proposed acquisition of a majority stake in a French CRO, as previously announced on 13 October 2025…
Actusnews Wire
27/02/2026
Oxurion Receives Transparency Notification from Atlas Special Opportunities II…
Leuven, BELGIUM – February 25, 2026 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on February 23, 2026, from Atlas Special Opportunities…
Actusnews Wire
25/02/2026
Oxurion Receives Transparency Notification from Atlas Special Opportunities II…
Leuven, BELGIUM – February 19, 2026 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on February 18, 2026, from Atlas Special Opportunities…
Actusnews Wire
19/02/2026
THERANEXUS : THX Pharma Reports Its Cash Position as of December 31, 2025
Lyon, France – February 19, 2026, 6:00 p.m. CET – THX Pharma (Theranexus), an innovative biopharmaceutical company specializing in the treatment of rare neurological diseases, today announces the publication of its cash position as of December 31, 2025. As of December 31, 2025, available cash amounted to €7,764 thousand, compared with €1,979…
Actusnews Wire
19/02/2026
ATON APPOINTS HADRIEN LANVIN AS DEPUTY CEO
Illkirch, February 18, 2026 – 6.30 pm Aton Group (Euronext Growth Paris - FR0004153930 - ALTAO), a leader in life sciences and medical technology, today announced the appointment of Hadrien Lanvin as Deputy Chief Executive Officer. Alumnus of HEC Paris, Hadrien Lanvin is the Founder and CEO of biotechnology firm Evora Biosciences…
Actusnews Wire
18/02/2026
Playful Nordic design – what is the secret formula?
Industrial News Service
16/02/2026
OXURION : Axiodis CRO accelerates its sales and marketing strategy to support…
Toulouse, France – February 16, 2026 – 8:00 a.m. Axiodis CRO, a subsidiary of the Oxurion Group (Euronext Brussels: OXUR) specializing in clinical data management, announces a major milestone in the implementation of its development strategy: the recruitment of its first dedicated sales representative and a marketing manager, in addition to the…
Actusnews Wire
16/02/2026
OXURION : Axiodis CRO versnelt zijn commerciële en marketingstrategie om…
Toulouse, Frankrijk – 16 februari 2026 – 08h00. Axiodis CRO, een dochteronderneming van de Oxurion-groep (Euronext Brussel: OXUR), gespecialiseerd in het beheer van klinische gegevens, kondigt een belangrijke stap aan in de uitvoering van haar ontwikkelingsstrategie: de aanwerving van een eerste toegewijde salesmedewerker en een marketingmanager…
Actusnews Wire
16/02/2026
BASTIDE : Organic growth of 8.2% in first-half 2025-2026: Confirmed excellent…
Caissargues, February 12, 2026 – Groupe Bastide, a leading European provider of home healthcare services, has published its revenue for first-half 2025-2026, ending December 31, 2025. In € millions 2024-2025 published 2024-2025 restated* 2025-2026 published Change First-quarter revenue 133.8 116.9 126.3 +8.0% Second-quarter revenue 141.5 124.1 134…
Actusnews Wire
12/02/2026
THERANEXUS : THX Pharma to Host a Webinar to Discuss Its Strategic Agreement…
THX Pharma to Host a Webinar to Discuss Its Strategic Agreement with Biocodex Lyon, France – February 12, 2026 – 6:00 p.m. CET – THX Pharma (Theranexus), an innovative biopharmaceutical company focused on the treatment of rare neurological diseases, announces that it will host a live webinar on Tuesday, February 17 at 6:00 p.m…
Actusnews Wire
12/02/2026
THERANEXUS : THX Pharma and Biocodex announce a strategic licensing agreement…
Biocodex has acquired two licenses from THX Pharma to develop and commercialize Batten-1 worldwide and TX01 in the United States and Canada. The total deal value is up to €173 million, including a €12 million upfront payment, up to €161 million in development and commercialization milestone payments, and tiered double-digit royalties on net sales…
Actusnews Wire
10/02/2026
Lumibird was selected by Rheinmetall for the Skyranger 30 air defence system
Lumibird was selected by Rheinmetall for the Skyranger 30 air defence system The LUMIBIRD Group (FR0000038242 – LBIRD), the European leader in laser technologies, announces that its subsidiary Lumibird Photonics Sweden AB has secured a new order from Rheinmetall Air Defence for its VIDAR laser rangefinders, to be integrated into the Skyranger 30 air defence system delivered to the Netherlands…
Actusnews Wire
09/02/2026
Oxurion Receives Transparency Notification from Atlas Special Opportunities II…
Leuven, BELGIUM – January 26, 2026 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on January 23, 2026, from Atlas Special Opportunities…
Actusnews Wire
26/01/2026
Lumibird: FY revenue of EUR 225.6 million (+10.2% at constant scope and exchange…
Lumibird: FY revenue of €225.6 million (+10.2% at constant scope and exchange rates) Growth of +10.2% at constant scope and exchange rates (+8.9% reported) Photonics Division: revenue of €113.4 million, strong growth (+15.0% at constant scope and exchange rates and +14.1% reported) confirming a clear return to growth, supported by a solid fourth…
Actusnews Wire
26/01/2026
Oxurion Receives Transparency Notification from Atlas Special Opportunities II…
Leuven, BELGIUM – January 23, 2026 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on January 22, 2026, from Atlas Special Opportunities…
Actusnews Wire
23/01/2026
Who belongs in the playground?
Industrial News Service
23/01/2026
THERANEXUS : THX Pharma Announces its 2026 Financial Calendar
Lyon, France – January 20, 2026, 18:00 p.m. CET – THX Pharma (Theranexus), an innovative biopharmaceutical company in the treatment of rare neurological diseases, today announces its financial communication agenda for. Each publication will be released after Euronext market closing, unless otherwise specified …
Actusnews Wire
20/01/2026
OXURION : Information on the Total Number of Voting Rights (Denominator)…
Atlas Special Opportunities, LLC has converted 2 convertible bonds in Oxurion resulting in a EUR 50,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment[1]. Leuven, BELGIUM – 19 januari 2026 – 06:00 PM CET – In accordance with article 15 of the Belgian Act of May 2, 2007 on the disclosure of…
Actusnews Wire
19/01/2026
DMS GROUP : EUR 50.0 MILLION IN ANNUAL REVENUE IN 2025, ORGANIC GROWTH OF +9%
Dynamic growth of +17% in activity in Q4 2025, driven by sustained international development Confirmed acceleration in growth in the 2nd half of 2025 (+14% vs. +3% in the 1st half of 2025) despite a wait-and-see market environment, particularly in France and Europe Strong development in the North American market, the main contributor to the Group's…
Actusnews Wire
19/01/2026
Oxurion kondigt de tijdelijke opschorting aan van het financieringsprogramma…
Leuven, BELGIË – 19 januari 2026 – 8u00 CET Oxurion NV (Euronext Brussel: OXUR), een farmaceutische onderaannemingsvennootschap gevestigd in Leuven, heeft het investeringsproject in digitale activa en crypto-activa, zoals op 1 december 2025 aan de markt werd meegedeeld, herbekeken. Dit project had tot doel een alternatieve activaklasse te…
Actusnews Wire
19/01/2026
Oxurion announces the temporary suspension of the financing programme dedicated…
Leuven, BELGIUM – January 19, 2026 – 08:00 AM CET - Oxurion NV (Euronext Brussels: OXUR), a pharmaceutical outsourcing company based in Leuven, has reviewed the investment project in digital assets and crypto-assets, as communicated to the market on 1 December 2025. The objective of this project was to consider an alternative asset class…
Actusnews Wire
19/01/2026
Klea Holding reports profitable growth of 34% in turnover in 2025 at constant…
Strong performance (+25% at constant currency) in the Medical Fitness segment. Revenue from the Medical Fitness segment & other services increased by a factor of 2.5. Confirmation of the target for strong EBITDA growth in 2025. First digital medical centre to open soon in Saudi Arabia. Paris, 19 January 2026 KLEA HOLDING (FR0013481835 – ALKLH), a…
Actusnews Wire
19/01/2026
Oxurion Receives Transparency Notification from Atlas Special Opportunities II…
Leuven, BELGIUM – January 13, 2026 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on January 9, 2026, from Atlas Special Opportunities II…
Actusnews Wire
13/01/2026
Evondos Group Launches in UK, delivering impressive £1.46m annualised savings in…
Industrial News Service
13/01/2026
Altri Comunicati
